QIAGEN and Max Planck Institute for Infection Biology collaborate to develop assay for active TB risk in individuals with latent infection
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt: Prime Standard: QIA) and the Max Planck Institute for Infection Biology (MPIIB), D…